Group 1 - Small-cap stocks exhibit higher volatility and activity compared to large-cap stocks, making them more likely to become market leaders [1] - As of January 19, there are 828 stocks with a circulating market value below 3 billion yuan, and 309 stocks with a circulating market value below 2 billion yuan [1] - A total of 1,502 stocks have a total market value below 5 billion yuan, with 463 stocks having a total market value below 3 billion yuan [1] Group 2 - The three stocks with the smallest circulating market values are *ST Changyao at 0.154 billion yuan, *ST Aowei at 0.274 billion yuan, and *ST Lifang at 0.429 billion yuan [1] - The three stocks with the smallest total market values are *ST Changyao at 0.154 billion yuan, *ST Aowei at 0.309 billion yuan, and *ST Lifang at 0.430 billion yuan [1] - A detailed list of stocks with circulating market values below 2 billion yuan includes various sectors such as pharmaceuticals, defense, and technology [1][2]

Core Viewpoint - Wanbang Medical emphasizes the importance of shareholder interests and market value management, aiming to enhance intrinsic value through steady operations and protect investor interests [2] Group 1 - The company is actively monitoring developments in AI healthcare and other fields [2] - Wanbang Medical commits to timely information disclosure regarding any significant matters as per relevant regulations [2]

Group 1 - The core point of the article is that Wanbang Medical announced the approval of a proposal to use part of its idle raised funds (including over-raised funds) and self-owned funds for cash management at its first extraordinary shareholders' meeting in 2026 [2]

证券代码：301520 证券简称：万邦医药 公告编号：2026-001 安徽万邦医药科技股份有限公司 2026 年第一次临时股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东会未出现否决议案的情形。 2、本次股东会未涉及变更以往股东会已通过的决议。 一、会议召开和出席情况 （一）会议召开情况 1、会议召开时间： 3、会议召开方式：本次会议采取现场投票和网络投票相结合的方式召开。 4、会议召集人：公司董事会。 5、会议主持人：董事长陶春蕾女士。 6、本次会议的召集、召开符合《中华人民共和国公司法》《上市公司股东会 规则》《深圳证券交易所创业板股票上市规则》等有关法律、行政法规、部门规 章、规范性文件和《安徽万邦医药科技股份有限公司章程》的有关规定。 （二）会议出席情况 截至本次股东会股权登记日 2026 年 1 月 8 日（星期四），公司总股本为 66,666,667 股，公司有表决权的股份总数 66,261,767 股。 1、股东出席的总体情况 出席本次股东会现场会议和网络投票表决的股东及股东授权委托代表共 71 人，代表 ...

安徽承义律师事务所 法律意见书 _________________________________________________________________________________ 安徽承义律师事务所 关于安徽万邦医药科技股份有限公司 2026 年第一次临时股东会的 法律意见书 安徽承义律师事务所 ANHUI CHENGYI LAW FIRM 地址：合肥市政务区怀宁路 200 号栢悦中心大厦五楼、八楼 邮编：230071 电话：0551-65609815 传真：0551-65608051 1 安徽承义律师事务所 法律意见书 安徽承义律师事务所 关于安徽万邦医药科技股份有限公司 2026年第一次临时股东会的法律意见书 (2026)承义法字第00004号 致：安徽万邦医药科技股份有限公司 安徽承义律师事务所（以下称"本所"）接受安徽万邦医药科技股份有限公司（以 下称"公司"）的委托，指派本律师以现场及线上方式出席公司 2026 年第一次临时 股东会（以下称"本次股东会"），对本次股东会的合法性进行见证。 本律师根据《中华人民共和国公司法》（以下称"《公司法》"）、《中华人民 共和国证券法》（以下简称 ...

Group 1 - The core point of the article is that Wanbang Medical reported the number of its shareholders as of January 9, 2026, which stands at 7,686 households [2]

Market Overview - The Shanghai Composite Index is at 4164.11 points, slightly above the six-month moving average, with a change of -0.03% [1] - The total trading volume of A-shares today is 185.05 billion yuan [1] Stocks Breaking the Six-Month Moving Average - A total of 168 A-shares have surpassed the six-month moving average today [1] - Notable stocks with significant deviation rates include: - Nearshore Protein (近岸蛋白) with a deviation rate of 19.69% and a price increase of 19.99% [1] - Erkang Pharmaceutical (尔康制药) with a deviation rate of 17.97% and a price increase of 19.14% [1] - Wanbang Pharmaceutical (万邦医药) with a deviation rate of 12.41% and a price increase of 12.85% [1] Stocks with Smaller Deviation Rates - Stocks with smaller deviation rates that have just crossed the six-month moving average include: - Bo Wen Technology (博闻科技) with a deviation rate just above the average [1] - Jilin Expressway (吉林高速) and Teda Investment (泰达股份) also show minor deviations [1] Additional Notable Stocks - Other stocks with notable performance include: - Deer Medical (鹿得医疗) with a price increase of 13.63% and a deviation rate of 11.86% [1] - Chuaning Biological (川宁生物) with a price increase of 12.84% and a deviation rate of 10.67% [1] - New Zhi Biological (新芝生物) with a price increase of 14.33% and a deviation rate of 10.66% [1]

Group 1 - The core point of the article is that Wanbang Pharmaceutical (301520) has disclosed its shareholder count, which is projected to reach 7,790 households by December 31, 2025 [1]

Group 1 - The company, Wanbang Medical, emphasizes its compliance with national and local laws and regulations regarding employee rights [2] - The company provides various benefits for employees, including maternity leave, breastfeeding leave, and parental leave, ensuring the protection of employees' reproductive rights [2]

Group 1 - The article highlights that small-cap stocks exhibit higher volatility and activity compared to large-cap stocks, making them more likely to become market leaders [1] - As of December 30, there are 949 stocks with a circulating market value below 3 billion yuan, and 374 stocks with a circulating market value below 2 billion yuan [1] - A total of 1,632 stocks have a total market value below 5 billion yuan, with 580 stocks having a total market value below 3 billion yuan [1] Group 2 - The three stocks with the smallest circulating market values are *ST Changyao at 333 million yuan, *ST Aowei at 453 million yuan, and Kuntai Co. at 637 million yuan [1] - The three stocks with the smallest total market values are *ST Changyao at 333 million yuan, *ST Aowei at 510 million yuan, and Dongtong Tui at 686 million yuan [1] - A detailed list of stocks with circulating market values below 2 billion yuan includes various sectors such as pharmaceuticals, defense, automotive, and more, with notable examples like *ST Changyao and *ST Aowei [1][2]